Suppr超能文献

[采用¹³¹I和化疗药物明胶微球经肝动脉栓塞治疗肝癌:9例报告]

[Hepatic carcinoma treated by hepatic arterial embolization using 131I and chemotherapeutic agent gelatin microspheres: report of 9 cases].

作者信息

Chen X, Wu Y, Zhong D, Li L, Tan T, Xie X, Yan C, Li X

机构信息

Academia Sinica, Chengdu Institute of Organic Chemistry.

出版信息

Hua Xi Yi Ke Da Xue Xue Bao. 1992 Sep;23(4):420-3.

PMID:1338993
Abstract

Nine patients with inoperable hepatoma were treated by using hepatic arterial embolization 131I and chemotherapeutic agent gelatin microsphere (131I-CA-GM). The emission CT after operation detected that the microspheres were concentrated on tumor area. The ratio between the radioactivity in tumor and that in liver was 4.1:1. A case died of ictopic embolization; the others survived 3, 4, 5, 19, 24, 7, 8, and 12 months respectively. Three of them were still alive. 131I-CA-GM has triple anticarcinogenic actions, including the arterial occlusion, targeting chemotherapy and internal radiation. The microspheres can selectively accumulate in the tumor artery and can be easily traced by gamma-camera or emission CT. 131I-CA-GM is a hopeful embolic agent for the treatment of liver cancer, but some problems about ectopic arterial embolization should be further studied.

摘要

9例无法手术切除的肝癌患者接受了肝动脉栓塞131I与化疗药物明胶微球(131I-CA-GM)联合治疗。术后发射型计算机断层扫描(ECT)检测到微球集中在肿瘤区域。肿瘤与肝脏放射性之比为4.1:1。1例死于异位栓塞;其他患者分别存活3、4、5、19、24、7、8和12个月。其中3例仍存活。131I-CA-GM具有动脉闭塞、靶向化疗和内照射三重抗癌作用。微球可选择性地在肿瘤动脉中积聚,并且可以通过γ相机或发射型计算机断层扫描轻松追踪。131I-CA-GM是一种有希望用于治疗肝癌的栓塞剂,但关于异位动脉栓塞的一些问题仍需进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验